Cancer Genetics to Present New Data From Renal Cell Carcinoma Study at AACRGlobeNewswire (press release)Metastatic ccRCC is well known for its aggressive nature and poor prognosis, with approximately 20-40% of patients relapsing within 5 years of nephr…
India Today |
British PM skips morning jog because of pollution
Times of India He advised people to listen to the official public health advice urging those with lung or heart problems to avoid strenuous physical activity outdoors. Data from Britain’s environment ministry showed pollution levels were “very high” — ten on a scale … Warning issued after Saharan dust lands in EnglandIndia Today London smog forces British PM Cameron to skip jogBusiness Standard Sahara Dust Pollution Britons Told to Stay InsideGuardian Liberty Voice Sky News all 753 news articles » |
IBNLive |
Team India says Yuvraj Singh fit for World T20 semi-final
IBNLive Yuvraj, who was man of the match during India’s World Cup-winning campaign in 2011, was diagnosed with a rare lung cancer later that year and received chemotherapy treatment in the United States. Team India says Yuvraj Singh fit for World T20 semi … India say Yuvraj fit for World T20 semi-finalYahoo!7 News |
Competitor Analysis: Biosimilar and Biosuperior Therapeutic AntibodiesSYS-CON Media (press release)The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of…
Times of India |
Yuvraj Singh fit for World T20 semifinal against South Africa
Times of India Yuvraj, who was man of the match during India’s World Cup-winning campaign in 2011, was diagnosed with a rare lung cancer later that year and received chemotherapy treatment in the United States. Meanwhile, Indian spinner Ravichandran Ashwin … |
Mirror.co.ukScientists calculate odd ways to dieMirror.co.uk… 25,000 people a year. More people die from snakebite in India than in any other country in the world, with the total death toll estimated I to average 10 – 12,000 annually. … aged under …
Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic …MarketWatch… OMS721 Phase 2 clinical trial, planned to begin later this quarter, will evaluate the effects of the drug on patients with TMAs, including atypical hemolytic…
|
Kamada Announces US Proof-of-Concept Study with Glassia® for Graft-Versus …
Business Wire (press release) The POC study is a Phase 1/2 study of 24 patients with steroid-resistant GVHD following allogeneic bone-marrow stem cell transplant who will receive six to ten doses of intravenously delivered Glassia to determine safety, optimal dose and clinical … |
Merck KGaA and Pfizer collaborate on lupusPMLiVECurrently most treatments available for SLE, typically corticosteroids, non-steroidal anti-inflammatory drugs and immunosuppresants, target the symptoms of the disease rather than its underlying pathology…
FEATURE: Organ donation awareness: recipients and donors570 NewsApril is BeADonor month, and the week of April 21-26 is National Organ and Tissue Donation Awareness Week. Organs that can be transplanted are the liver, small bowel, kidney, pancreas, hea…